Gregory D. Cascino
Affiliations: | Neurology | Mayo Clinic, Rochester, MN, United States |
Area:
EpilepsyGoogle:
"Gregory Cascino"Bio:
Professor of Neurology, Mayo Clinic College of Medicine; Chair, Division of Epilepsy, Mayo Clinic, Rochester, MN. Head, Section of Epilepsy, Mayo Clinic
Area of interest: epilepsy, surgical treatment of epilepsy,use of electronic devices for epilepsy. First publication (first author) was with RD Adams (Neurology 1986, Brainstem Auditory Hallucinosis). Mentor: RD Adams
Mean distance: 14.49 (cluster 3) | S | N | B | C | P |
Parents
Sign in to add mentorRaymond D. Adams | grad student | 1982-1986 | Massachusetts General Hospital/Harvard Medical School | |
(resident) | ||||
Allan H. Ropper | grad student | 1982-1986 | Massachusetts General Hospital/Harvard Medical School | |
(resident) |
Collaborators
Sign in to add collaboratorWalter J. Koroshetz | collaborator | 1982-1985 | Massachusetts General Hospital/Harvard Medical School |
BETA: Related publications
See more...
Publications
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
Weil EL, Stitt DW, Rabinstein AA, et al. (2022) Acute Ischemic Stroke Presentation Masked by Falsely Localizing Motor Seizure: A Clinical Case Series. The Neurohospitalist. 12: 647-650 |
Bank AM, Kuzniecky R, Knowlton RC, et al. (2022) Structural Neuroimaging in Adults and Adolescents With Newly Diagnosed Focal Epilepsy: The Human Epilepsy Project. Neurology |
Simpson HD, Schulze-Bonhage A, Cascino GD, et al. (2022) Practical considerations in epilepsy neurostimulation. Epilepsia |
Triplett JD, Simpson HD, Clemmons RS, et al. (2021) The effect of weight reduction surgery on the efficacy and tolerability of epilepsy pharmacotherapy. Epilepsy & Behavior : E&B. 124: 108307 |
Wheless JW, Miller I, Hogan RE, et al. (2021) Final results from a Phase 3, long-term, open-label, repeat-dose safety study of diazepam nasal spray for seizure clusters in patients with epilepsy. Epilepsia |
Miller I, Wheless JW, Hogan RE, et al. (2021) Consistent safety and tolerability of Valtoco (diazepam nasal spray) in relationship to usage frequency in patients with seizure clusters: Interim results from a phase 3, long-term, open-label, repeat-dose safety study. Epilepsia Open |
Cascino GD, Tarquinio D, Wheless JW, et al. (2021) Lack of observed tolerance to diazepam nasal spray (Valtoco®) after long-term rescue therapy in patients with epilepsy: Interim results from a phase 3, open-label, repeat-dose safety study. Epilepsy & Behavior : E&B. 120: 107983 |
Segal EB, Tarquinio D, Miller I, et al. (2021) Evaluation of diazepam nasal spray in patients with epilepsy concomitantly using maintenance benzodiazepines: An interim subgroup analysis from a phase 3, long-term, open-label safety study. Epilepsia |
Smith KM, Zalewski NL, Budhram A, et al. (2021) Musicogenic epilepsy: Expanding the spectrum of glutamic acid decarboxylase 65 neurological autoimmunity. Epilepsia |
Tatum WO, Hirsch LJ, Gelfand MA, et al. (2021) Video Quality Using Outpatient Smartphone Videos in Epilepsy: Results from the OsmartViE Study. European Journal of Neurology |